Orion Oyj (OTCMKTS:ORINF – Get Free Report) is expected to be posting its resultson Friday, July 17th. Analysts expect Orion Oyj to announce earnings of $1.09 per share and revenue of $577.0710 million for the quarter.
Orion Oyj Price Performance
Shares of OTCMKTS:ORINF opened at $82.75 on Friday. Orion Oyj has a fifty-two week low of $78.95 and a fifty-two week high of $82.75. The firm’s 50-day simple moving average is $82.75 and its 200-day simple moving average is $81.36.
About Orion Oyj
Orion Oyj is a Finland-based pharmaceutical and diagnostic products company that develops, manufactures and markets both human and veterinary medicines, diagnostic tests and active pharmaceutical ingredients. With a history dating back to its founding in 1917, the company has evolved into a diversified life science group, offering prescription and over-the-counter products for neurological, respiratory, cardiovascular and urological conditions, among others. Orion’s human pharmaceuticals portfolio includes well-known treatments for Parkinson’s disease, hormone therapy and erectile dysfunction, while its veterinary range addresses animal health needs such as pain management and dermatology.
In its Diagnostics segment, Orion produces laboratory tests and instruments for clinical chemistry and immunoassay applications, focusing on hormone and drug monitoring.
Recommended Stories
- Five stocks we like better than Orion Oyj
- PriceSmart Stock Eyes $220 as Chile Expansion Fuels Growth
- Dollar Tree’s Turnaround Is Starting to Take Root
- Why Levi’s Digital Strategy Is Paying Off in a Big Way
- Constellation Brands: Beer Growth and Buybacks Mask Stock’s Slump
Receive News & Ratings for Orion Oyj Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orion Oyj and related companies with MarketBeat.com's FREE daily email newsletter.
